Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 9526
Country/Region: South Africa
Year: 2012
Main Partner: Partnership for Supply Chain Management
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $11,432,678

In the FY12 period, SCMS will scope, plan and implement an effective pooled procurement and distribution mechanism for quality ARVs to be delivered to select PEPFAR Implementing Partners (IPs). Efficiency, availability, quality management and reduced stock obsolescence for ARVs will be the key program components. SCMS will assist the IPs in developing a pooled procurement model which enables ARVs to be efficiently procured and distributed while complying with the regulations and governance requirements of both PEPFAR and the GSA. The program will provide assistance in strengthening the IPs capacity and capability to develop efficient, sustainable long term healthcare supply chains which are sustainable. SCMS will leverage partnerships and private sector capacity, driving supply chain efficiencies, executing appropriate commodity consolidation and/or rapid response to distribution of ARVs.IP collaboration will be essential in developing this procurement and distribution approach, with clearly defined roles and responsibilities to establish the expected outcomes, timelines and deliverables for all the stakeholders.SCMS will receive $6,000,000 of the one-time VMMC funding for RSA to do a pooled procurement of disposable MMC kits. Kits will be distributed to USAID, DOD, and CDC IPs. This will optimize bulk discounts and simplify kit procurement and distribution. SCMS provides procurement, forecasting, distribution, inventory management, and quality assurance on the kits. While the VMMC target for one-time funding is 260,000, additive kits are required to accommodate training, errors, and potential exceeding of performance targets. It is estimated that at a price of $16.5 - $17 per kit, this procurement should render 352,000 363,000 single-use kits.

Funding for Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC): $6,000,000

SCMS will receive $6,000,000 of the one-time VMMC funding for South Africa to do a pooled procurement of disposable MMC kits. Kits will be distributed to USAID, DOD, and CDC implementing partners. This will optimize bulk discounts and simplify kit procurement and distribution. SCMS provides procurement, forecasting, distribution, inventory management, and quality assurance on the kits. While the VMMC target for one-time funding is 260,000, additive kits are required to accommodate training, errors, and potential exceeding of performance targets. It is estimated that at a price of $16.5 - $17 per kit, this procurement should render 352,000 363,000 single-use kits.

Funding for Treatment: ARV Drugs (HTXD): $5,432,678

The initial technical support phase will design the ARV supply chain management system in conjunction with the IPs and regulatory requirements. While the USG ARV Bridging Fund program experience will provide the foundation, there are some significant differences in the procurement and distribution under the IP program which will require consideration.Key principles which require planning with the IPs include 1) implementing pooled procurement and distribution methods, to consolidate procurement orders and increasing volumes with which to negotiate lead times and freighting options to enable cost savings while supporting availability of ARVs, 2) developing well-planned quantification, procurement and distribution mechanisms to avert stock outs, overstocks, and emergency purchases through shared data, 3) developing an agreed IPs ARV list to pool procurement optimizing cost benefits, supporting harmonization with current guidelines, patient clinical requirements and the ultimate transition of patients to mainstream public sector service facilities.SCMS will provide technical assistance support, determine and obtain necessary regulation/governance approvals, completing an analysis with IPs to determine supply chain requirements, collating an approved or tentatively approved FDA and MCC list of ARVs, identifying the options to obtain SEP exemption, agreeing a pooled procurement consolidated distribution model to plan warehousing and ordering procedures, determining quality assurance procedures and establishing M&E systems.Once the technical approach is agreed, the SCMS operational support team will manage the forecasting, procurement, logistical requirements and provide M&E tracking for the selected ARVs from the regulated manufacturers to the IP healthcare facility sites. Aside from building supply chain management efficiencies for the ARVs shared SCMS expertise and knowledge across the partnerships will support the development of supply chain best practices for IPs to implement across their practices.